5don MSN
Novo Nordisk’s New Weight Loss Shot Loses To Rival Eli Lilly In Clinical Trial—Stock Plummets
Novo’s CagriSema shot was shown to be less effective than rival Lilly’s tirzepatide ...
The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...
The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss of Eli Lilly’s Zepbound.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results